Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
Flu Vaccine Didn't Stop Vascular Events in Heart Failure Patients But study in lower income countries sees hint of benefit during peak disease season Apr 04, 2022
EHR Pop-Ups Spur Better GDMT Implementation in Heart Failure Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor? EMPEROR-Preserved trial weighs in Mar 21, 2022
ARB-Cancer Link May Come Down to Cumulative Exposure Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
Salt in Fizzy Tablets Linked to Heart, Death Risk Warning signals seen for fast-acting acetaminophen and other drugs Feb 24, 2022
A Simple Way to Tell When Asymptomatic Aortic Stenosis Isn't So Benign Could regular NT-proBNP testing be of value to patients with non-severe AS? Feb 16, 2022
ACIP Embraces Spikevax Amid Serious Talk of Changing mRNA Dosing Interval Would longer time between doses do the trick to reduce myocarditis risk? Feb 04, 2022
Caution: Paxlovid Interacts With Many Heart Meds The Skeptical Cardiologist asks clinicians and patients to take note Jan 17, 2022
Death During Sex: Not Just an Old Man Thing But sudden cardiac death remains rare even for sexually active people with heart conditions Jan 12, 2022
The Right Ventricle Still Matters in LVAD Patients Right heart failure signaled trouble ahead in the Intermacs registry Nov 29, 2021
Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patients Beta-blockers may not benefit HFpEF patients with chronotropic incompetence Nov 15, 2021
Stem Cells Don't Prevent Acute Heart Failure Events DREAM-HF trial does hold some positive signals, though Nov 15, 2021
Tricuspid Repair Boosts Mitral Valve Surgery Outcomes Randomized trial supports combined surgery for moderate regurgitation Nov 13, 2021
Delaying Surgery Hurts Patients With Silent Aortic Stenosis Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
Pulmonary Pressure Monitoring Helps HFpEF Too GUIDE-HF substudy supports similar benefits across the ejection fraction spectrum Nov 07, 2021
More Good News for Empagliflozin in Patients With Heart Failure Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
Longstanding Vascular Closure Technique Triumphs Over Collagen Plug Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
TAVR Operators Divided on Need for Bicuspid RCT Odds of a study coming to fruition are low Nov 05, 2021
Too Many TAVR Centers Are Clustered Around Well-to-Do Communities More centers not the answer to geographic, socioeconomic disparities in access? Oct 22, 2021
Study: Kids Exposed to Harmful Plastics During Heart Surgery Are tubing and blood bags sources of trouble? Oct 09, 2021
Post-TAVR Pacemakers Not All Doom and Gloom A bit of reassurance from Swedish cohort study Oct 04, 2021
Low Risk and Bicuspid Anatomy: A Passable Combination for TAVR Thus Far Clinical outcomes not worse compared with tricuspid TAVR Sep 21, 2021
With HVAD Out, Innovation Key to Mechanical Circulatory Support A debate on where LVAD innovation stands Sep 14, 2021
Transplant Docs Are Sticking With Invasive Biopsies After Heart Transplants Agreement that non-invasive alternatives to EMB are not ready for routine rejection surveillance Sep 13, 2021
SGLT2 Inhibitor Eases Symptoms for HFpEF Patients Trial suggests hard outcomes not the only ones helped by this class of medication Sep 13, 2021
Second-Gen Drug for HCM Emerges, Nipping at Mavacamten's Heels Novel cardiac myosin inhibitor is headed for a phase III trial Sep 12, 2021
Heart Failure's 'Golden Moment' Not Translating into Better Health Problems of implementation and health equity persist Sep 12, 2021
Feared ARNI Effect on Cognition Hasn't Come to Fruition Neurocognitive protection by sacubitril/valsartan suggested instead by observational study Sep 12, 2021
Some Reassurance on Cognition in People With Older LVADs Will newer devices look even better for neurological outcomes? Sep 08, 2021
Good Results When Giving Flu Shots to MI Survivors Still in the Hospital Vaccination prior to discharge linked to heart benefit Aug 30, 2021
Polypills Ready for Prime Time in Large Swaths of People, Researchers Say Question now is how to implement fixed-dose combo therapy in clinical practice Aug 29, 2021
His Bundle Pacing Stars in European Guidelines Revised edition could signal coming U.S. recommendations too Aug 29, 2021
Ablation, CRT Boost Survival in Permanent Afib With Narrow QRS APAF-CRT trial reinforces the case for expanded CRT indication Aug 28, 2021
Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. There is a different approach to deciding the suitability of TAVR, however Aug 28, 2021
A Familiar Drug Can Keep Early-Stage HCM at Bay Treatment with valsartan most beneficial when started early? Aug 27, 2021
Empagliflozin Improves Outcomes in HFpEF Patients "A major win" for heart failure with preserved ejection fraction, says editorialist Aug 27, 2021
New Heart Failure Guidelines Released, but Are They Already Out of Date? Results of EMPEROR-Preserved contradict guidance Aug 27, 2021
